This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harbeck, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harbeck, R. J.

Next Article 

Clinical and Diagnostic Laboratory Immunology, May 1998, p. 271-277, Vol. 5, No. 3
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

MINIREVIEW

Immunophenotyping of Bronchoalveolar Lavage Lymphocytes

Ronald J. Harbeck*

National Jewish Medical and Research Center, Denver, Colorado

    INTRODUCTION
Top
Introduction
Methods
Conclusions
References

The lung is continuously exposed to the external environment and its mixtures of complex antigens through the air we breathe. It is estimated that the resting human adult inhales 12,000 liters of air each day, while even mild physical activity can double or triple this amount (85). In addition to anatomical barriers, such as airway angulation, mucociliary clearance, and coughing, both humoral and cellular defense mechanisms play an important role in maintaining the viability of the host. One of the first lines of defense against particulate matter is mucociliary clearance and phagocytic activity of alveolar macrophages. Antigen entering the pulmonary tract encounters antigen-presenting cells comprised of alveolar and interstitial macrophages and effector T lymphocytes (reviewed in reference 1). This encounter leads to a complex sequence of events that results in cell migration and activation at a site of inflammation, with the subsequent development of lymphocyte functional effector activity. After many years of study there is still a paucity of information on the origin, half-life, fate, and specific function of pulmonary lymphocytes in health and disease (80).

Protective immunity against inhaled antigens is mediated by the lymphocytes that are localized to the surface of the respiratory tract. The compartments in the lung where lymphocytes are present are (i) the epithelium and lamina propria of the air-conducting regions, (ii) the bronchus-associated lymphoid tissue (BALT), which is found commonly in certain animals, i.e., rabbit and rats, (iii) the pulmonary interstitium and vascular beds, and (iv) the bronchoalveolar space. Lymphocytes present in the mucociliary epithelium of the trachea and bronchi are mainly CD8+ T cells. In the bronchial epithelium Fournier et al. (34) found 18 T cells per 100 epithelial cells but essentially no B cells. About 1% of these T cells express the gamma delta T-cell receptor (31). In contrast to the epithelium, the bronchial lamina propria contains more CD4+ than CD8+ T cells. The majority of these T cells express the memory marker of CD45RO (25). Also, this area shows more surface immunoglobulin-bearing lymphocytes (54). In the human, in contrast to rabbits and rats, BALT is present at birth but disappears in the adult lung. However, after certain stimuli such as cigarette smoking, BALT can develop in adults (90). In the whole human lung interstitium Holt et al. (51) calculated 10 × 109 lymphocytes, a number equivalent to the number of lymphocytes present in human circulating blood.

Lymphocytes in the bronchoalveolar space are the most easily accessible of the lymphocytes in the human lung. It has been estimated that the total number of these lymphocytes on the air side of the epithelium is between 2 × 108 and 4 × 108 (22, 54). This number represents about 5% of the total circulating lymphocyte pool in humans or about 5% of the size of the interstitial lung pool.

    BAL

Much of our understanding of the role of pulmonary lymphocytes in host defense mechanisms and in disease comes from the study of lymphocytes recovered from the lung by bronchoalveolar lavage (BAL). BAL is the sampling of the lower respiratory tract by the instillation and subsequent aspiration of fluid (59). The technique recovers cells, soluble proteins, lipids, and other chemical constituents from the epithelial surface of the lungs. Clinically, BAL has been helpful in the diagnosis and differentiation of various types of lung diseases including interstitial lung diseases, malignancies, and pulmonary infections (53). It also has been used in defining the stages of disease, its progression, and response to therapy. As a research tool, it is useful in the investigation of the cellular and humoral events occurring in lungs, especially in pulmonary diseases, and has aided in advancing hypotheses regarding disease pathogenesis and especially immunopathogenesis.

The European Respiratory Society and the American Thoracic Society have published guidelines and recommendations for fiber-optic bronchoscopy and BAL (4, 30). In brief, the technique of BAL generally involves the introduction of a flexible fiber-optic bronchoscope transnasally while the patient is in a semirecumbent position (59, 67). It is passed through the pharynx and vocal cords, into the trachea, and to the appropriate area of the lung. In localized disease, lavage of the involved lung segment is more likely to yield the best results, while in diffuse disease, the right middle lobe or lingula has been most commonly used because of the ease of access and the increased volume and cells recovered compared to other sites. Aliquots of sterile saline (generally 30 to 40 ml) are instilled through the bronchoscope, which is immediately and gently withdrawn. The total volume of saline instilled has been reported to range from 30 to 400 ml. In general, 20% is recovered after the first instillation of saline followed by 40 and 70% recovery in subsequent instillations. One-hundred milliliters of saline will sample the constituents of about 106 alveoli or about 1.5 to 3% of the lung and will recover about 1 ml of epithelial-lining fluid. The total procedure takes less than 15 min.

    CELLS AND PROTEINS RECOVERED FROM BAL

The cells recovered from the lung by lavage are much more heterogeneous than the cells obtained from peripheral blood. The major cell populations include macrophages, neutrophils, eosinophils, erythrocytes, and lymphocytes (67, 100). Less frequently, mast cells, plasma cells, ciliated squamous epithelial cells, Langerhans cells, megakaryocytes, erythroid precursors or immature myeloid cells, alveolar type I and II epithelial cells, and endothelial cells are recovered. During inflammation and injury in the lung, epithelial cells increase significantly. Pulmonary macrophage size can range from 8 to 30 µm or larger, while BAL fluid lymphocytes can be larger than their peripheral blood counterparts depending on the condition of the lung and especially if they are activated (23). Common nonpulmonary materials recovered from the BAL fluid include nonpathogenic fungi, talc, carbon pigments, ferruginous bodies, hair, mineral fibers, pollen granules, starch granules, and vegetable cells (100). All of these cells and substances can confuse the light scatter profiles when specific populations of cells such as lymphocytes are analyzed by flow cytometry.

Most normal serum proteins are present in BAL fluid including immunoglobulins, albumin, alpha 1-antitrypsin, and alpha 2- macroglobulin (53). In addition, complement, carcinoembryonic antigen (CEA), transferrin, fibronectin, collagenase, lipids, and prostaglandins are all detected in the BAL. They arrive there as a result of either local synthesis (e.g., surfactant), active transport (e.g., immunoglobulin M), or passive transudation (e.g., albumin). With some exceptions, proteins with a molecular mass greater than 300,000 Da are not present in BAL fluid.

Over 80% of the cells recovered from normal individuals are macrophages, with smokers showing more than 90% macrophages (7). Lymphocytes account for roughly 10% of the cell types, with the remaining cells being neutrophils, basophils, and eosinophils (generally less than 1%). The subsets of T lymphocytes in the normal adult human lung closely parallel those seen in the peripheral blood; i.e., roughly 65 to 75% are CD3+ cells, 40 to 45% are CD4+ cells, and 20 to 25% are CD8+ cells. The B cells are fewer, generally under 5%. Analysis of the T-cell repertoire from the lungs of normal individuals indicates a largely polyclonal pattern corresponding to that found in peripheral blood (12). Yurovsky et al. showed that the pulmonary T-cell repertoire is diverse in normal subjects and that the repertoire changes over time, which may reflect environmental exposures (122). Ratjen et al. studied the lymphocyte surface markers of BAL fluid in 28 children ranging in age from 3 to 16 years without bronchopulmonary disease (86). The distribution of total T and B cells was similar to that reported for adults; however, there was an increase in the CD8 subset of T cells giving rise to a lower CD4/CD8 ratio (0.7 ± 0.4 [mean ± standard deviation]) than that for adult BAL cells.

    PROCESSING OF BAL FOR CELL COUNTS, DIFFERENTIALS, AND IMMUNOPHENOTYPING

Unfortunately, there is no consensus on the processing of BAL samples for cell counts, differentials, and immunophenotyping, and as a consequence, there is a myriad of different methods described in the literature. If the BAL contains too much mucus (rare in individuals without inflammatory airway disease) or visible particulate material, it has been most frequently reported to be filtered through cotton gauze (59), although investigators have used nylon gauze (56), Dacron nets (44), 100-mesh grid (40), stainless-steel mesh (16, 38), and venous infusion filters (42, 43). One of the concerns with filtering BAL fluids is that there may be selective loss of cell populations or subpopulations to a filter, especially if the specimen contains activated cells. Our laboratory rarely filters BAL fluids unless the amount of mucus impairs our ability to analyze lymphocyte populations.

Cell counts are made by counting an aliquot on a hemocytometer, for example, a Neubauer, Malassez, Burker, or Fuchs-Rosenthal counting chamber (59). One report indicates that Türk solution is used as an aid in counting (104). The use of an automated hematology analyzer has also been described (79, 81, 107, 109, 118). The problem with the latter is that these instruments are capable of distinguishing cell types in peripheral blood but are not so good at fluid analysis such as BAL analysis. Frequently, cell viabilities are performed by the Trypan blue dye exclusion technique (7).

For differentials of the leukocytes, a conventional-cytocentrifuge preparation or smears are air dried and stained with a hematologic stain such as Wright-Giemsa, Diff-Quik, or May-Grunwald-Giemsa (7, 30). At least 200, but more frequently 500 to 1,000, cells are counted and classified as lymphocytes, neutrophils, eosinophils, macrophages, basophils, or epithelial cells. However, the imprecision of a differential has been repeatedly emphasized, especially when small numbers of cells are used (60, 94). As with blood, the enumeration of specific lymphocyte subsets in BAL is often dependent on a multiplatform, three-stage process. The final lymphocyte number is the product of the leukocyte count, the percentage of leukocytes that are lymphocytes, and the percentage of lymphocytes that have a particular subset marker. Thus, the resulting multiplication steps for determining the total lymphocyte count can have a magnified imprecision. There have been reports of selective loss of lymphocytes by cytocentrifugation or from smears due to the poor adherence of lymphocytes to glass slides, which is exacerbated during an aqueous staining process (72). Esterase staining is often employed to distinguish macrophages from lymphocytes (59, 64).

The overwhelming number of cells in the BAL are macrophages. Some investigators remove these cells prior to lymphocyte immunophenotyping by adherence to plastic in media such as RPMI, which is frequently supplemented with a source of protein, e.g., 10% fetal calf serum (36, 55, 58, 66, 73-75) for 30 min to 1 h or by the magnetic removal of ingested carbonyl iron (40, 88). Further depletion of alveolar macrophages has been reported with complement-mediated lysis and anti-CD11c (123) or passage through a nylon wool column (3). As mentioned above, one must be aware that activated T cells could also bind to plastics, etc. This is especially important since several studies have analyzed BAL lymphocytes for activation markers, i.e., CD69, CD25, and HLA-DR (5, 16, 19, 25, 71, 73, 74, 79, 92, 102, 108-110). For isolation of specific T-cell subset populations, one report used rosetting with neuraminidase-treated sheep erythrocytes followed by isolation by Ficoll-Hypaque gradient centrifugation (40).

    METHODS TO ENUMERATE LYMPHOCYTE POPULATIONS IN BAL
Top
Introduction
Methods
Conclusions
References

Diseases and conditions for which the immunophenotyping of BAL fluid lymphocytes has been investigated include sarcoidosis (8, 9, 25, 27, 32, 33, 43, 44, 52, 55, 63, 71, 75, 87, 102, 120); hypersensitivity pneumonitis (6, 17, 27, 87); asthma (21, 38, 40, 50, 56, 61, 69, 79, 83, 92, 96, 99, 107, 109, 110, 119); infectious diseases including human immunodeficiency virus (2, 45, 57, 85, 111, 123), tuberculosis (3, 49, 97, 121), human T-cell lymphotropic virus type I infection (74, 101), and hepatitis C virus infection (62); lung transplantion (16, 88, 117, 118); collagen vascular diseases (36, 42, 114, 115); malignant lung diseases (35, 82, 89, 93, 98, 105, 116); allogeneic bone marrow transplantation (66); alcoholic liver cirrhosis (113); pulmonary diseases associated with eosinophilia (108); bronchiolitis (20, 28, 58, 73); radiation pneumonitis (41, 43, 91); and beryllium disease (77).

Several of these diseases show an increase in the lymphocytes recovered in BAL fluids. These include hypersensitivity pneumonitis, sarcoidosis, berylliosis, tuberculosis, various drug-induced lung diseases, asbestosis, some collagen vascular diseases, and human immunodeficiency virus infections (1). The distribution of CD4 and CD8 in the BAL but not in the blood is abnormal in disorders such as sarcoidosis and hypersensitivity pneumonitis, while a normal distribution of CD4 and CD8 cells is frequently seen in tuberculosis and lymphangiosis carcinomatosa (17, 52, 65). In sarcoidosis and hypersensitivity pneumonitis, the lymphocyte percentage can range from 30 to 70% of the total number of cells (17). In sarcoidosis the ratio of CD4/CD8 cells can be as high as 10:1 to 20:1, while in hypersensitivity pneumonitis the ratio is decreased or reversed.

Some of the main indications for performing immunophenotyping of BAL lymphocytes are disorders with increased lymphocyte counts such as sarcoidosis and hypersensitivity pneumonitis. The methods of enumerating lymphocyte populations have included immunocytochemistry with visible-light microscopy, fluorescent-antibody staining with fluorescence microscopy, and flow cytometry. Immunocytochemistry and immunofluorescence have been frequently used for enumerating lymphocyte subpopulations in BAL fluids by observational scoring of single cells for the presence or absence of a particular marker.

Immunoperoxidase is frequently used in immunocytochemistry to enumerate lymphocyte populations in the BAL fluids in patients with a variety of pulmonary diseases (43, 49, 84, 86, 96, 104). The peroxidase-antiperoxidase technique is time-consuming, and the accuracy and reliability of the results depend on the number of cells counted and the experience of the observer. In this procedure, as originally described by Bross et al. (11) and later adapted by Costabel et al. (18), aliquots of cells from BAL are placed on glass slides or commercially available adhesion slides. The slides are next fixed with glutaraldehyde. Nonspecific antibody binding is prevented by preincubation of the slide with a gelatin-containing medium. In a humidified chamber the slides are first incubated with monoclonal antibodies to human CD antigens. This step is followed by incubating the slides with rabbit anti-mouse and swine anti-rabbit immunoglobulin. Finally, the rabbit peroxidase-antiperoxidase immunocomplex is added followed by the substrate (diaminobenzidine). Negative controls follow the above procedure except that the primary antibody is omitted. Positive cells are cells which show dark brown granular staining of the cell membrane. Lymphocyte subset evaluation has also been carried out by an alkaline phosphatase-anti-alkaline phosphatase immunocytochemical method (8, 37, 40, 120). It has been reported that this method along with fast red for visualization avoids the difficulty of nonspecific staining because of endogenous peroxidase (16).

On occasion, fluorescence microscopy along with monoclonal antibodies has also been used to enumerate specific lymphocyte subpopulations in BAL fluids (26, 27, 36, 39, 113, 114). In this method a suspension of the BAL cells is incubated with mouse monoclonal antibodies to specific lymphocyte subsets, washed, and stained with fluoresceinated anti-mouse serum. After a further incubation, the cells are again washed and examined by fluorescence microscopy. At least 200 cells which have morphological features of lymphocytes are scored for positive staining. As noted for the immunoperoxidase technique, the accuracy and reliability of the results are dependent on the experience of the observer. Good correlation between immunofluorescence microscopy and immunocytochemistry has been demonstrated for lymphocytes in BAL fluids (106).

    ENUMERATION OF LYMPHOCYTE POPULATIONS IN BAL BY FLOW CYTOMETRY

The guidelines developed for laboratories performing lymphocyte immunophenotyping of peripheral blood has allowed a greater degree of standardization of flow-cytometric techniques for the enumeration of specific lymphocyte subsets, especially CD4+ cells (13-15, 76). These guidelines have provided recommendations for specimen collection, specimen transport to the laboratory where the analysis will be carried out, specimen processing, the monoclonal antibody panels to be used, positive and negative controls for immunophenotyping, flow cytometer quality control, sample analyses, data analysis, data storage, and quality assurance. Unfortunately, guidelines have not been established for the immunophenotyping of lymphocytes from non-peripheral blood fluids such as BAL. The absence of uniformity in lymphocyte immunophenotyping of BAL fluids has made comparisons between various reports difficult.

There are several important issues to be aware of in enumerating BAL lymphocyte populations by flow cytometry (48). While data can be obtained more rapidly by flow cytometry, often the heterogeneity of the cellular populations makes analysis difficult and can lead to the exclusion of cells of interest as well as the inclusion of unwanted cells. The light scatter patterns often show overlapping clusters of cells and debris, with specific lymphocyte populations being difficult to delineate. Cellular autofluorescence and nonspecific binding can be strong and can obscure or mimic specific staining of low-expression markers. If attention is not paid to the specific technical issues, the analysis can yield inaccurate results.

The technique of obtaining BAL can itself often lead to dead cells or naked nuclei. Generally, the viability of cells recovered from the BAL is greater than 80% but rarely exceeds 90% (7). In addition, BAL samples are frequently contaminated with erythrocytes. This can pose specific problems in lymphocyte analysis since erythrocytes show light scatter characteristics similar to those of lymphocytes, which can lead to an underestimation of the true lymphocyte percentages. While many reports fail to mention if erythrocytes are removed, several have indicated the use of erythrocyte lysing reagents including ammonium chloride (42, 108-110, 112) and commercial lysing reagents (29, 56, 57, 91, 107). Mild hypotonic lysis has also been used to remove erythrocyte contamination (5). However, any lysing method could lead to the release of cellular debris and interfere with the lymphocyte gating purity.

As flow technology has progressed, investigators have gone from a one-color approach to two- and three-color approaches for enumerating lymphocyte populations in BAL fluids and from an indirect-staining approach to direct staining. The use of isotype controls to distinguish positively stained cells from background staining has varied widely. After staining, most investigators fix the cells with 0.5 to 1% paraformaldehyde or formaldehyde prior to analysis. Commonly, 5,000 to 10,000 cells are counted; however, the number of gated events counted varies widely, ranging from several hundred cells (112) to 20,000 cells (58, 73-75).

The quality of the results from flow cytometry depends on the nature and quality of the lymphocyte gate. Gating becomes easier and less of a problem in analysis when there is an increase in the percentage (greater than 10%) and number of lymphocytes in the BAL. Most published studies have used a variety of methods to establish lymphocyte gates in analyzing BAL including light scatter only (i.e., forward scatter [size] by side scatter [granularity]), the combination of CD14 and CD45 along with light scatter to estimate the percentage of nonlymphocyte contamination of the gated area, light scatter with CD3 positive selection, the combination of side scatter and CD45, BAL lymphocyte gates defined by the light scatter characteristics of peripheral blood lymphocytes, and the use of commercial software programs. References for these methods are given in Table 1.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   Gating methods used for BAL lymphocyte immunophenotyping

Several publications have used lymphocyte gating methods relying solely on forward and side scatter properties (Table 1). This can lead to inaccuracies in the data due to the exclusion or inclusion of nonlymphoid cells. Often, macrophages in the BAL may exhibit the same light scatter profile as the lymphocytes, in which case the errors would be made in determining the size of a particular lymphocyte population. Identification of lymphocytes within a forward by side scatter histogram with the use of CD45 and CD14 to aid in distinguishing lymphocytes from the various other nonlymphoid populations of cells improves the reliability of the results and also allows the purity of the gated population to be estimated. CD45 is expressed on macrophages and granulocytes but at lower levels than lymphocytes (68). However, under the best of conditions, the percentage of CD45 bright cells (or lymphocytes) and CD14-negative cells is frequently less than 75%. This is especially true when the percent and number of lymphocytes in the BAL fluid are low. The use of CD14 to identify alveolar macrophages in a gated lymphocyte population is limited by the fact that only 70 to 90% of alveolar macrophages express this marker (46).

Brandt et al. (10) assessed lymphocyte subsets by flow cytometry with a tricolor staining procedure. They adapted a procedure originally published by Terstappen et al. (103) in which the fluorescent DNA dye LDS 751 was used to exclude damaged cells and debris. Lymphocytes are identified by their CD45 expression, side scatter, and cellular integrity. Comparing this procedure to an immunocytochemical method, the authors found a strong correlation with the percentages of CD3+, CD4+, and CD8+ cells. Weak or no correlation was found between CD25+ and CD56+ cells, probably due to the low number of these cells counted with the immunocytochemical method.

Dauber et al. (24) used the combination of the common leukocyte antigen CD45 and side scatter to gate on BAL lymphocyte populations obtained from normal individuals and allograft recipients. Using this gating procedure, they were able to exclude events that were not leukocytes including erythrocytes (not staining with CD45) and cellular debris that would normally fall into the forward by side scatter gates. In addition, they used an additional fluorescent marker to identify specific T-cell subsets. When the authors examined the correlation between this CD45/side scatter gating method and the traditional forward/side scatter method or an immunocytochemical analysis, they found a good correlation to the immunocytochemical method for CD3+, CD4+, and CD8+ cells. However, as expected, the forward/side scatter analysis did not correlate well with the immunocytochemical method. The advantage of using CD45 and side scatter to gate on lymphocytes is that large lymphocytes are not excluded from analysis, since forward scatter is not used to select the cells. However, as the authors point out, selecting lymphocytes by CD45 expression and side scatter can underestimate high side scatter, large granular lymphocytes expressing CD16. By expanding the side scatter gate, one runs the risk of including CD45-positive macrophages in the analysis. Another potential problem is the presence of CD45-positive degranulated neutrophils in the BAL fluid. These cells, which may have arisen as a result of activation upon passage into the alveolar spaces, have side scatter characteristics, which allows them to fall within the lymphocyte gate.

The use of three-color analysis with gating on CD45+ and side scatter as proposed for whole-blood analysis may offer an acceptable alternative to two-color analysis of BAL lymphocytes (78). In this procedure, lymphocytes are identified by their side scatter and bright CD45 expression, with the subsets of T cells identified by CD3 and CD4 or CD8. The combination of CD3 with CD4 or CD8 ensures that these markers are measured only on T cells. In a limited number of BAL samples examined in our laboratory, three-color analysis, e.g., CD45/CD3/CD4 and CD45/CD3/CD8, showed good correlation with two-color analysis of BAL lymphocytes, e.g., CD3/CD4 and CD3/CD8, when CD45/CD14 was used to gate on the lymphocyte populations (47).

Padovan et al. compared flow cytometry to the conventional peroxidase-antiperoxidase method for the immunophenotyping of BAL cells obtained from patients with various interstitial lung diseases (81). Comparable results were obtained for CD3+, CD4+, CD8+, and CD57+ cells. The authors found that HLA-DR-positive lymphocytes could be measured more reliably by flow cytometry than by the immunoperoxidase method due to the fact that the continuum of expression for HLA-DR with a shift in fluorescence intensity was more easily detected by flow cytometry than by the subjective measure of immunoperoxidase.

    SUMMARY AND CONCLUSIONS
Top
Introduction
Methods
Conclusions
References

In summary, analysis of lymphocytes in BAL fluid has been important in our understanding of the pathophysiology of pulmonary diseases and has been useful in diagnosing various pulmonary inflammatory conditions. Standard methods used in the enumeration of lymphocytes from peripheral blood by flow cytometry may not always be applicable to the analysis of BAL in part due to the potential for heterogeneous populations of cells and nonpulmonary materials present. The development of a standardized procedure for the processing and immunophenotyping of BAL lymphocytes will make comparisons between various reports easier.

    FOOTNOTES

* Mailing address: National Jewish Medical and Research Center, 1400 Jackson St., Denver, CO 80206. Phone: (303) 398-1337. Fax: (303) 398-1780. E-mail: harbeck.njc.org.

    REFERENCES
Top
Introduction
Methods
Conclusions
References

1. Agostini, C., M. Chilosi, R. Zambello, L. Trentin, and G. Semenzato. 1993. Pulmonary immune cells in health and disease: lymphocytes. Eur. Respir. J. 6:1378-1401[Abstract].
2. Agostini, C., V. Poletti, R. Zambello, L. Trentin, F. Siviero, L. Spiga, F. Gritti, and G. Semenzato. 1988. Phenotypical and functional analysis of bronchoalveolar lavage lymphocytes in patients with HIV infection. Am. Rev. Respir. Dis. 138:1609-1615[Medline].
3. Ainslie, G. M., J. A. Solomon, and E. D. Bateman. 1992. Lymphocyte and lymphocyte subset numbers in blood and in bronchoalveolar lavage and pleural fluid in various forms of human pulmonary tuberculosis at presentation and during recovery. Thorax 47:513-518[Abstract/Free Full Text].
4. American Thoracic Society. 1990. Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am. Rev. Respir. Dis. 142:481-486[Medline].
5. Ancochea, J., A. Gonzalez, M. J. Sanchez, J. Aspa, and M. Lopez-Botet. 1993. Expression of lymphocyte activation surface antigens in bronchoalveolar lavage and peripheral blood cells from young healthy subjects. Chest 104:32-37[Abstract/Free Full Text].
6. Ando, M., K. Konishi, R. Yoneda, and M. Tamura. 1991. Difference in the phenotypes of bronchoalveolar lavage lymphocytes in patients with summer-type hypersensitivity pneumonitis, farmer's lung, ventilation pneumonitis, and bird fancier's lung: report of a nationwide epidemiologic study in Japan. J. Allergy Clin. Immunol. 87:1002-1009[Medline].
7. BAL Cooperative Group Steering Committee. 1990. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am. Rev. Respir. Dis. 141:S169-S202[Medline].
8. Barbosa, I. L., V. A. Gant, and A. S. Hamblin. 1991. Alveolar macrophages from patients with bronchogenic carcinoma and sarcoidosis similarly express monocyte antigens. Clin. Exp. Immunol. 86:173-178[Medline].
9. Bellocq, A., D. Lecossier, C. Pierre-Audigier, A. Tazi, D. Valeyre, and A. J. Hance. 1994. T cell receptor repertoire of T lymphocytes recovered from the lung and blood of patients with sarcoidosis. Am. J. Respir. Crit. Care Med. 149:646-654[Abstract].
10. Brandt, B., M. Thomas, M. von Eiff, and G. Assmann. 1996. Immunophenotyping of lymphocytes obtained by bronchoalveolar lavage: description of an all-purpose tricolor flow cytometric application. J. Immunol. Methods 194:95-102[Medline].
11. Bross, K. J., G. A. Pangalis, C. G. Staatz, and K. G. Blume. 1978. Demonstration of cell surface antigens and their antibodies by the peroxidase-antiperoxidase method. Transplantation 25:331-338[Medline].
12. Burastero, S. E., B. Borgonovo, D. Gaffi, E. Frittoli, A. Wack, G. A. Rossi, and E. E. Crimi. 1996. The repertoire of T-lymphocytes recovered by bronchoalveolar lavage from healthy nonsmokers. Eur. Respir. J. 9:319-327[Abstract].
13. Centers for Disease Control and Prevention. 1992. Guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus infection. Morbid. Mortal. Weekly Rep. 41(RR-8):1-121.
14. Centers for Disease Control and Prevention. 1994. Revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (HIV) infection. Morbid. Mortal. Weekly Rep. 43(RR-3):1-17.
15. Centers for Disease Control and Prevention. 1997. Revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). Morbid. Mortal. Weekly Rep. 46(RR-2):1-29[Medline].
16. Clelland, C., T. Higenbottam, S. Stewart, B. Otulana, T. Wreghitt, J. Gray, J. Scott, and J. Wallwork. 1993. Bronchoalveolar lavage and transbronchial lung biopsy during acute rejection and infection in heart-lung transplant patients: studies of cell counts, lymphocyte phenotypes, and expression of HLA-DR and interleukin-2 receptor. Am. Rev. Respir. Dis. 147:1386-1392[Medline].
17. Costabel, U. 1988. The alveolitis of hypersensitivity pneumonitis. Eur. Respir. J. 1:5-9[Abstract].
18. Costabel, U., K. J. Bross, and H. Matthys. 1985. The immunoperoxidase slide assay: a new method for the demonstration of surface antigens on bronchoalveolar lavage cells. Bull. Eur. Physiopathol. Respir. 21:381-387[Medline].
19. Costabel, U., K. J. Bross, K. H. Ruhle, G. W. Lohr, and H. Matthys. 1990. Ia-like antigens on T-cells and their subpopulations in pulmonary sarcoidosis and in hypersensitivity pneumonitis. Am. Rev. Respir. Dis. 131:337-342.
20. Costabel, U., H. Teschler, and J. Guzman. 1992. Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage. Eur. Respir. J. 5:791-797[Abstract].
21. Crump, J. W., R. J. Pueringer, and G. W. Hunninghake. 1991. Bronchoalveolar lavage and lymphocytes in asthma. Eur. Respir. J. 4:39s-46s.
22. Crystal, R. G., P. B. Bitterman, S. I. Rennard, A. J. Hance, and B. A. Keogh. 1984. Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. N. Engl. J. Med. 310:154-166[Medline].
23. Dauber, J. H., M. D. Rossman, and R. P. Daniele. 1979. Bronchoalveolar cell populations in sarcoidosis: observations in smoking and non-smoking patients. J. Lab. Clin. Med. 94:862-871[Medline].
24. Dauber, J. H., M. Wagner, S. Brunsvold, and I. L. Paradis. 1992. Flow cytometric analysis of lymphocyte phenotypes in bronchoalveolar lavage fluid: comparison of a two-color technique with the standard immunoperoxidase assay. Am. J. Respir. Cell Mol. Biol. 7:531-541.
25. Dominique, S., F. Bouchonnet, J. M. Smiejan, and A. J. Hance. 1990. Expression of surface antigens distinguishing "naive" and previously activated lymphocytes in bronchoalveolar lavage fluid. Thorax 45:391-396[Abstract/Free Full Text].
26. Drent, M., H. van Velzen-Blad, M. Diamant, H. C. Hoogsteden, and J. M. van den Bosch. 1993. Relationship between presentation of sarcoidosis and T lymphocyte profile: a study in bronchoalveolar lavage fluid. Chest 104:795-800[Abstract/Free Full Text].
27. Drent, M., S. Wagenaar, H. van Velzen-Blad, P. G. Mulder, H. C. Hoogsteden, and J. M. van den Bosch. 1993. Relationship between plasma cell levels and profile of bronchoalveolar lavage fluid in patients with subacute extrinsic allergic alveolitis. Thorax 48:835-839[Abstract/Free Full Text].
28. Emmerich, B., H. P. Emslander, K. Pachmann, M. Hallek, D. Milatovic, and R. Busch. 1990. Local immunity in patients with chronic bronchitis and the effects of a bacterial extract, Broncho-Vaxom, on T lymphocytes, macrophages, gamma-interferon and secretory immunoglobulin A in bronchoalveolar lavage fluid and other variables. Respiration 57:90-99[Medline].
29. Erle, D. J., T. Brown, D. Christian, and R. Aris. 1994. Lung epithelial lining fluid T cell subsets defined by distinct patterns of beta 7 and beta 1 intergrin expression. Am. J. Respir. Cell Mol. Biol. 10:237-244[Abstract].
30. European Society of Pneumology Task Group on BAL. 1989. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Eur. Respir. J. 2:561-585[Medline].
31. Fajac, I., A. Tazi, A. J. Hance, F. Bouchonnet, M. Riquet, J. P. Battesti, and P. Soler. 1992. Lymphocytes infiltrating normal human lung and lung carcinomas rarely express gamma delta T cell antigen receptors. Clin. Exp. Immunol. 87:127-131[Medline].
32. Forrester, J. M., L. S. Newman, Y. Wang, T. E. King, and B. L. Kotzin. 1993. Clonal expansion of lung Vdelta 1 T cells in pulmonary sarcoidosis. J. Clin. Invest. 91:292-300.
33. Forrester, J. M., Y. Wang, N. Ricalton, J. E. Fitzgerald, J. Loveless, L. S. Newman, T. E. King, and B. L. Kotzin. 1994. TCR expression of activated T cell clones in the lungs of patients with pulmonary sarcoidosis. J. Immunol. 153:4291-4302[Abstract].
34. Fournier, M., R. Lebargy, F. Le Roy Ladurie, E. Lenormand, and R. Pariente. 1989. Intraepithelial T-lymphocyte subsets in the airways of normal subjects and of patients with chronic bronchitis. Am. Rev. Respir. Dis. 140:737-742[Medline].
35. Fracchia, A., M. Pacetti, M. Barberis, M. A. Mura, C. LeGrazie, and E. Longhini. 1987. Determination of T-lymphocyte subpopulations in patients with lung cancer: a comparison between lung lavage and peripheral blood by monoclonal antibodies and flow cytometry. Respiration 51:161-169[Medline].
36. Frigieri, L., F. Mormile, N. Grilli, D. Mancini, G. Ciappi, G. Pagliari, M. Magaro, and G. Flamini. 1991. Bilateral bronchoalveolar lavage in progressive systemic sclerosis: interlobar variability, lymphocyte subpopulations, and functional correlations. Respiration 58:132-140[Medline].
37. Gant, V. A., and A. S. Hamblin. 1985. Human alveolar macrophage heterogeneity demonstrated by histochemistry, surface markers and phagocytosis. Clin. Exp. Immunol. 60:539-545[Medline].
38. Gardiner, P. V., C. Ward, H. Booth, A. Allison, D. J. Hendrick, and E. H. Walters. 1994. Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. Am. J. Respir. Crit. Care Med. 150:1006-1011[Abstract].
39. Garlepp, M. J., A. H. Rose, R. V. Bowman, N. Mavaddat, J. Dench, B. J. Holt, M. Baron-Hay, P. G. Holt, and B. W. Robinson. 1992. A clonal analysis of lung T cells derived by bronchoalveolar lavage of healthy individuals. Immunology 77:31-37[Medline].
40. Gerblich, A. A., H. Salik, and M. R. Schuyler. 1991. Dynamic T-cell changes in peripheral blood and bronchoalveolar lavage after antigen bronchoprovocation in asthmatics. Am. Rev. Respir. Dis. 143:533-537[Medline].
41. Ginns, L. C., P. D. Goldenheim, R. C. Burton, R. B. Colvin, L. G. Miller, G. Goldstein, C. Hurwitz, and H. Kazemi. 1982. T lymphocyte subsets in peripheral blood and lung lavage in idiopathic pulmonary fibrosis and sarcoidosis: analysis by monoclonal antibodies and flow cytometry. Clin. Immunol. Immunopathol. 25:11-15[Medline].
42. Groen, H., M. Aslander, H. Bootsma, T. W. van der Mark, and C. G. M. Kallenberg. 1993. Bronchoalveolar lavage cell analysis and lung function impairment in patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 94:127-133[Medline].
43. Groen, H., M. Hamstra, R. Aalbers, T. W. van der Mark, G. H. Koeter, and D. S. Postma. 1994. Clinical evaluation of lymphocyte subpopulations and oxygen radical production in sarcoidosis and idiopathic pulmonary fibrosis. Respir. Med. 88:55-64[Medline].
44. Grunewald, J., C. H. Janson, A. Eklund, M. Ohrn, O. Olerup, U. Persson, and H. Wigzell. 1992. Restricted V alpha 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur. J. Immunol. 22:129-135[Medline].
45. Guillon, J. M., B. Autron, M. Denis, P. Foret, F. Plata, and C. M. Mayaud. 1988. Human immunodeficiency virus-related lymphocytic alveolitis. Chest 94:1264-1270[Abstract/Free Full Text].
46. Hance, A. J., S. Douches, R. J. Winchester, V. J. Ferrans, and R. G. Crystal. 1985. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis. J. Immunol. 134:284-292[Abstract].
47. Harbeck, R. J. 1996. Bronchoalveolar lavage analysis by flow cytometry. Presented at the Ninth International Symposium on Infections in the Immunocompromised Host .
48. Harbeck, R. J., W. Townend, R. F. Vogt, and J. B. Margolick. 1993. Methodologic considerations for analyzing leukocytes in bronchoalveolar lavage fluid by flow cytometry. Cytometry 6:45.
49. Hoheisel, G. B., L. Tabak, H. Teschler, F. Erkan, C. Kroegel, and U. Costabel. 1994. Bronchoalveolar lavage cytology and immunocytology in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 149:460-463[Abstract].
50. Hol, B. E., F. H. Krouwels, B. Bruinier, R. M. Reijneke, H. J. Mengelers, L. Koenderman, H. M. Jansen, and T. A. Out. 1992. Cloning of T lymphocytes from bronchoalveolar lavage fluid. Am. J. Respir. Cell Mol. Biol. 7:523-530.
51. Holt, P. G., B. W. S. Robinson, M. Reid, U. R. Kees, A. Warton, V. H. Dawson, A. Rose, M. Schon-Hegrad, and J. M. Papadimitriou. 1986. Extraction of immune and inflammatory cells from human lung parenchyma: evaluation of and enzymatic digestion procedure. Clin. Exp. Immunol. 66:188-200[Medline].
52. Hunninghake, G. W., and R. G. Crystal. 1981. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocytes at sites of disease activity. N. Engl. J. Med. 305:429-434[Abstract].
53. Hunninghake, G. W., J. E. Gadek, O. Kawanami, V. J. Ferrans, and R. G. Crystal. 1979. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am. J. Pathol. 97:149-206[Abstract].
54. Hunninghake, G. W., O. Kawanami, V. J. Ferrans, R. C. Young, W. C. Roberts, and R. G. Crystal. 1981. Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am. Rev. Respir. Dis. 123:407-412[Medline].
55. Iida, K., J. Kadota, K. Kawakami, Y. Matsubara, R. Shirai, and S. Kohno. 1997. Analysis of T cell subsets and beta chemokines in patients with pulmonary sarcoidosis. Thorax 52:431-437[Abstract].
56. Jaffar, Z. H., P. Sullivan, C. Page, and J. Costello. 1996. Low-dose theophylline modulates T-lymphocyte activation in allergen-challenged asthmatics. Eur. Respir. J. 9:456-462[Abstract].
57. Kagi, M. K., W. Fierz, P. J. Grob, and E. W. Russi. 1993. High proportion of gamma-delta T cell receptor positive T cells in bronchoalveolar lavage and peripheral blood of HIV-infected patients with Pneumocystis carinii pneumonias. Respiration 60:170-177[Medline].
58. Kawakami, K., J. Kadota, K. Iida, T. Fujii, R. Shirai, Y. Matsubara, and S. Kohno. 1997. Phenotypic characterization of T cells in bronchoalveolar lavage fluid (BALF) and peripheral blood of patients with diffuse panbronchiolitis; the importance of cytotoxic T cells. Clin. Exp. Immunol. 107:410-416[Medline].
59. King, T. E. 1992. The handling and analysis of bronchoalveolar lavage specimens, p. 3-29. In R. P. Baughman (ed.), Bronchoalveolar lavage. Mosby Year Book, St. Louis, Mo.
60. Koepke, J. A., and A. L. Landay. 1989. Precision and accuracy of absolute lymphocyte counts. Clin. Immunol. Immunopathol. 52:19-27[Medline].
61. Krug, N., J. Madden, A. E. Redington, P. Lackie, R. Djukanovic, U. Schauer, S. T. Holgate, A. J. Frew, and P. H. Howarth. 1996. T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am. J. Respir. Cell Mol. Biol. 14:319-326[Abstract].
62. Kubo, K., S. Yamaguchi, K. Fujimoto, M. Hanaoka, M. Hayasaka, T. Honda, T. Sodeyama, and K. Kiyosawa. 1996. Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection. Thorax 51:312-314[Abstract/Free Full Text].
63. Laviolette, M., J. La Forge, S. Tennina, and L. P. Boulet. 1991. Prognostic value of bronchoalveolar lavage lymphocyte count in recently diagnosed pulmonary sarcoidosis. Chest 100:380-384[Abstract/Free Full Text].
64. Lawrence, C., and R. Groffman. 1980. Simple butyrate esterase stain for monocytes. Stain Technol. 54:321-323.
65. Leatherman, J. W., A. F. Michael, B. A. Schwartz, and J. R. Hoidal. 1984. Lung T-cells in hypersensitivity pneumonitis. Ann. Intern. Med. 100:390-392.
66. Leblond, V., H. Zouabi, L. Sutton, J.-M. Guillon, C. M. Mayaud, T. Similowski, C. Beigelman, and B. Autran. 1994. Late CD8+ lymphocytic alveolitis after allogeneic bone marrow transplantation and chronic graft-versus-host disease. Am. J. Respir. Crit. Care Med. 150:1056-1061[Abstract].
67. Linder, J., and S. I. Rennard. 1988. Bronchoalveolar lavage. American Society of Clinical Pathologists Press, Chicago, Ill.
68. Loken, M. R., J. M. Brosnan, B. A. Bach, and K. A. Ault. 1990. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 11:453-459[Medline].
69. Maestrelli, P., M. Saetta, A. Di Stefano, P. G. Calcagni, G. Turato, M. P. Ruggieri, A. Roggeri, C. E. Mapp, and L. M. Fabbri. 1995. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am. J. Respir. Crit. Care Med. 152:1926-1931[Abstract].
70. Mancini, N. M., M. C. Bene, H. Gerard, F. Chabot, G. Faure, J. M. Polu, and O. Lesur. 1993. Early effects of short-time cigarette smoking on the human lung: a study of bronchoalveolar lavage fluids. Lung 171:277-291[Medline].
71. Mornex, J. F., G. Cordier, J. Pages, R. Lefebvre, J.-P. Revillard, J.-M. Vergnon, M. Vincent, J.-F. Cordier, and J. Brune. 1985. Pulmonary sarcoidosis: flow cytometry measurements of lung T cell activation. J. Lab. Clin. Med. 105:70-76[Medline].
72. Moumouni, H., P. Garaud, P. Diot, E. Lemarie, and P. Anthonioz. 1994. Quantification of cell loss during bronchoalveolar lavage fluid processing: effects of fixation and staining methods. Am. J. Respir. Crit. Care Med. 149:636-640[Abstract].
73. Mukae, H., J. Kadota, S. Kohno, S. Kusano, T. Morikawa, S. Matsukura, and K. Hara. 1995. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. Am. J. Respir. Crit. Care Med. 152:613-618[Abstract].
74. Mukae, H., S. Kohno, N. Morikawa, J. Kadota, S. Matsukura, and K. Hara. 1994. Increase in T-cells bearing CD25 in bronchoalveolar lavage fluid from HAM/TSP patients and HTLV-1 carriers. Microbiol. Immunol. 38:55-62[Medline].
75. Mukae, H., S. Kohno, T. Morikawa, S. Kusano, J. Kadota, and K. Hara. 1994. Two-color analysis of lymphocyte subsets of bronchoalveolar lavage fluid and peripheral blood in Japanese patients with sarcoidosis. Chest 105:1474-1480[Abstract/Free Full Text].
76. National Committee for Clinical Laboratory Standards. 1992. Clinical applications of flow cytometry: quality assurance and immunophenotyping of peripheral blood lymphocytes. H42-T. National Committee for Clinical Laboratory Standards, Wayne, Pa.
77. Newman, L. S., C. Bobka, B. Schumacher, E. Daniloff, B. Zhen, M. M. Mroz, and T. E. King. 1994. Compartmentalized immune response reflects clinical severity of beryllium disease. Am. J. Respir. Crit. Care Med. 150:135-142[Abstract].
78. Nicholson, J., P. Kidd, F. Mandy, D. Livnat, and J. Kagan. 1993. T lymphocyte determinations on whole blood specimens using a single-tube, three-color assay. Cytometry 14:685-689[Medline].
79. Oosterhoff, Y., H. C. Hoogsteden, B. Rutgers, H. F. Kauffman, and D. S. Postma. 1995. Lymphocyte and macrophage activation in bronchoalveolar lavage fluid in nocturnal asthma. Am. J. Resp. Crit. Care Med. 151:75-81[Abstract].
80. Pabst, R., and T. Tschernig. 1995. Lymphocytes in the lung: an often neglected cell. Numbers, characterization and compartmentalization. Anat. Embryol. 192:293-299[Medline].
81. Padovan, C. S., J. Behr, A.-M. Allmeling, J. T. Gerlach, C. Vogelmeier, and F. P. Krombach. 1992. Immunophenotyping of lymphocyte subsets in bronchoalveolar lavage fluid. J. Immunol. Methods 147:27-32[Medline].
82. Piazza, G., E. Marchi, F. Scaglione, C. C. Montoli, S. Losi, and G. Scarpazza. 1990. Lymphocyte subsets in bronchoalveolar lavage fluid and in circulating blood in epidermoid bronchogenic carcinoma. Respiration 57:28-36[Medline].
83. Picker, L. J., R. J. Martin, A. Trumble, L. S. Newman, P. A. Collins, P. R. Bergstresser, and D. Y. M. Leung. 1994. Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites. Eur. J. Immunol. 24:1269-1277[Medline].
84. Rak, S., G. Hallden, S. Sorenson, V. Margari, and A. Scheynius. 1993. The effect of immunotherapy on T-cell subsets in peripheral blood and bronchoalveolar lavage fluid in pollen-allergic patients. Allergy 48:460-465[Medline].
85. Rankin, J. A. 1988. Pulmonary immunology. Clin. Chest Med. 9:387-393[Medline].
86. Ratjen, F., M. Bredendiek, L. Zheng, M. Brendel, and U. Costabel. 1995. Lymphocyte subsets in bronchoalveolar lavage fluid of children without bronchopulmonary disease. Am. J. Respir. Crit. Care Med. 152:174-178[Abstract].
87. Raulf, M., V. Liebers, C. Steppert, and X. Baur. 1994. Increased gamma/delta-positive T-cells in blood and bronchoalveolar lavage of patients with sarcoidosis and hypersensitivity pneumonitis. Eur. Respir. J. 7:140-147[Abstract].
88. Reinsmoen, N. L., R. M. Bolman, K. Savik, K. Butters, and M. Hertz. 1992. Differentiation of class I- and class II-directed donor-specific alloreactivity in bronchoalveolar lavage lymphocytes from lung transplant recipients. Transplantation 53:181-189[Medline].
89. Reynolds, H. Y. 1987. Bronchoalveolar lavage. Am. Rev. Respir. Dis. 135:250-263[Medline].
90. Richmon, I., G. E. Pritchard, T. Ashcroft, A. Avery, P. A. Corris, and E. H. Walter. 1993. Bronchus-associated lymphoid tissue (BALT) in human lung: its distribution in smokers and non-smokers. Thorax 48:1130-1134[Abstract/Free Full Text].
91. Roberts, C. M., E. Foulcher, J. J. Zaunders, D. H. Bryant, J. Freund, D. Cairns, R. Penny, G. W. Morgan, and S. N. Breit. 1993. Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction. Ann. Intern. Med. 118:696-700[Abstract/Free Full Text].
92. Robinson, D. S., A. M. Bentley, A. Hartnell, A. B. Kay, and S. R. Durham. 1993. Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness. Thorax 48:26-32[Abstract/Free Full Text].
93. Rolla, G., C. Bucca, F. Chiampo, L. Brussino, E. Scappaticci, A. Stacchini, M. T. Bertero, and F. Caligaris-Cappio. 1993. Respiratory symptoms, lung function tests, airway responsiveness, and bronchoalveolar lymphocyte subsets in B-chronic lymphocytic leukemia. Lung 171:265-275[Medline].
94. Saltini, C., A. J. Hance, V. J. Ferrans, F. Basset, P. B. Bitterman, and R. G. Crystal. 1982. Accurate quantification of cells recovered by bronchoalveolar lavage. Am. Rev. Respir. Dis. 130:650-658.
95. Saltini, C., M. Kirby, B. C. Trapnell, N. Tamura, and R. G. Crystal. 1990. Biased accumulation of T-lymphocytes with "memory"-type CD45 leukocyte common antigen expression on the epithelial surface of the human lung. J. Exp. Med. 171:1123-1140[Abstract/Free Full Text].
96. Schmekel, B., and P. Venge. 1993. Markers for eosinophils and T-lymphocytes as predictors of late asthmatic response. Allergy 48:94-97[Medline].
97. Schwander, S. K., E. Sada, M. Torres, D. Escobedo, J. G. Sierra, S. Alt, and E. A. Rich. 1996. T lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis. J. Infect. Dis. 173:1267-1272[Medline].
98. Siminski, J., P. Kidd, G. D. Phillips, C. Collins, and G. Raghu. 1991. Reversed helper/suppressor T-lymphocyte ratio in bronchoalveolar lavage fluid from patients with breast cancer and Pneumocystis carinii pneumonia. Am. Rev. Respir. Dis. 143:437-440[Medline].
99. Smith, D. L., and R. D. DeShazo. 1993. Bronchoalveolar lavage in asthma: an update and perspective. Am. Rev. Respir. Dis. 148:523-532[Medline].
100. Stanley, M. W. 1991. Qualitative and quantitative cytology in control subjects, p. 27-64. In M. W. Stanley, M. J. Henry Stanley, and C. Iber (ed.), Bronchoalveolar lavage: cytology and clinical applications. Igahu-shoin Medical Publishers, New York, N.Y.
101. Sugimoto, M., S. Mita, M. Tokunaga, K. Yamaguchi, I. Cho, M. Matsumoto, M. Mochizuki, S. Araki, K. Takatsuki, and M. Ando. 1993. Pulmonary involvement in human T-cell lymphotropic virus type-I uveitis: T-lymphocytosis and high proviral DNA load in bronchoalveolar lavage fluid. Eur. Respir. J. 6:938-943[Abstract].
102. Suzuki, K., N. Tamura, A. Iwase, T. Dambara, and S. Kira. 1996. Prognostic value of Ia+ T lymphocytes in bronchoalveolar lavage fluid in pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 154:707-712[Abstract].
103. Terstappen, L. W., V. O. Shah, M. P. Conrad, D. Recktenwald, and M. R. Loken. 1988. Discriminating between damaged and intact cells in fixed flow cytometric samples. Cytometry 9:477[Medline].
104. Thomas, M., M. von Eiff, B. Brandt, A. Heinecke, and J. van de Loo. 1995. Immunophenotyping of lymphocytes in bronchoalveolar lavage fluid: a new flow cytometric method vs standard immunoperoxidase technique. Chest 108:464-469[Abstract/Free Full Text].
105. van Maarsseveen, T. C., J. Stam, and J. J. Calame. 1990. T lymphocytosis in a bronchoalveolar lavage of a pulmonary adenocarcinoma: case report. Respiration 57:57-61[Medline].
106. van Maarsseveen, T. C., H. Mullink, M. De Haan, J. De Groot, J. Stam, and C. J. L. M. Meijer. 1989. Simultaneous enumeration of T-cell subsets and macrophages in bronchoalveolar lavage fluids by immunoenzyme double staining: comparison with conventional immunofluorescence. Acta Cytol. 33:550[Medline].
107. Virchow, J. C., Jr., C. Walker, D. Hafner, C. Kortsik, P. Werner, H. Matthys, and C. Kroegel. 1995. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am. J. Respir. Crit. Care Med. 151:960-968[Abstract].
108. Walker, C., W. Bauer, R. K. Braun, G. Menz, P. Braun, F. Schwarz, T. T. Hansel, and B. Villiger. 1994. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am. J. Respir. Crit. Care Med. 150:1038-1048[Abstract].
109. Walker, C., E. Bode, L. Boer, T. T. Hansel, K. Blaser, and J. C. Virchow, Jr. 1992. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146:109-115[Medline].
110. Walker, C., M. K. Kaegi, P. Braun, and K. Blaser. 1991. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J. Allergy Clin. Immunol. 88:935-942[Medline].
111. Wallace, J. M., R. G. Barberis, J. S. Oishi, and H. Prince. 1984. Cellular and T-subpopulation profiles in bronchoalveolar lavage fluid from patients with acquired immunodeficiency syndrome and pneumonitis. Am. Rev. Respir. Dis. 130:786-792[Medline].
112. Wallace, J. M., J. S. Oishi, R. G. Barbers, M. S. Simmons, and D. P. Tashkin. 1994. Lymphocytic subpopulation profiles in bronchoalveolar lavage fluid and peripheral blood from tobacco and marijuana smokers. Chest 105:847-852[Abstract/Free Full Text].
113. Wallaert, B., J. F. Colombel, L. Prin, Y. Sibille, and A. B. Tonnel. 1992. Bronchoalveolar lavage in alcoholic liver cirrhosis: T-lymphocyte subsets and immunoglobulin concentrations. Chest 101:468-473[Abstract/Free Full Text].
114. Wallaert, B., L. Prin, P. Y. Hatron, P. Ramon, A. B. Tonnel, and C. Voisin. 1987. Lymphocyte subpopulations in bronchoalveolar lavage in Sjogren's syndrome: evidence for an expansion of cytotoxic/suppressor subset in patients with alveolar neutrophilia. Chest 92:1025-1031[Abstract/Free Full Text].
115. Wallaert, B., G. A. Rossi, and Y. Sibille. 1990. Collagen vascular disease. Eur. Respir. J. 3:942-943[Medline].
116. Weynants, P., J. F. Cordier, C. C. Cellier, J. Pages, R. Loire, and J. Brune. 1985. Primary immunocytoma of the lung: the diagnostic value of bronchoalveolar lavage. Thorax 40:542-543[Free Full Text].
117. Whitehead, B. F., C. Stoehr, C. Finkle, G. Patterson, J. Theodore, C. Clayberger, and V. A. Starnes. 1993. Distribution of TCR alpha beta+ and TCR gamma delta+ lymphocytes in bronchoalveolar lavage from human lung transplant recipients. Transplantation 56:1031-1034[Medline].
118. Whitehead, B. F., C. Stoehr, C. Finkle, G. Patterson, J. Theodore, C. Clayberger, and V. A. Starnes. 1995. Analysis of bronchoalveolar lavage from human lung transplant recipients by flow cytometry. Respir. Med. 89:27-34[Medline].
119. Wilson, J. W., R. Djukanovic, P. H. Howarth, and S. T. Holgate. 1992. Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma. Am. Rev. Respir. Dis. 145:958-960[Medline].
120. Xaubet, A., C. Agusti, J. Roca, C. Picado, and R. Rodriguez-Roisin. 1993. BAL lymphocyte activation antigens and diffusing capacity are related in mild to moderate pulmonary sarcoidosis. Eur. Respir. J. 6:715-718[Abstract].
121. Yu, C. T., C. H. Wang, T. J. Huang, H. C. Lin, and H. P. Kuo. 1995. Relation of bronchoalveolar lavage T lymphocyte subpopulations to rate of regression of active pulmonary tuberculosis. Thorax 50:869-874[Abstract/Free Full Text].
122. Yurovsky, V. V., E. R. Bleecker, and B. White. 1996. Restricted T-cell antigen receptor repertoire in bronchoalveolar T cells from normal humans. Hum. Immunol. 50:22-37[Medline].
123. Zambello, R., L. Trentin, R. Benetti, A. Cipriani, C. Crivellaro, P. Cadrobbi, C. Agostini, and G. Semenzato. 1992. Expression of a functional p75 interleukin-2 receptor on lung lymphocytes from patients with human immunodeficiency virus type 1 (HIV-1) infection. J. Clin. Immunol. 12:371-380[Medline].

Clinical and Diagnostic Laboratory Immunology, May 1998, p. 271-277, Vol. 5, No. 3
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • SLEBOS, D.-J., SCHOLMA, J., MARIKE BOEZEN, H., KOETER, G. H., VAN DER BIJ, W., POSTMA, D. S., KAUFFMAN, H. F. (2002). Longitudinal Profile of Bronchoalveolar Lavage Cell Characteristics in Patients with a Good Outcome after Lung Transplantation. Am. J. Respir. Crit. Care Med. 165: 501-507 [Abstract] [Full Text]  
  • Raju, B., Tung, C. F., Cheng, D., Yousefzadeh, N., Condos, R., Rom, W. N., Tse, D. B. (2001). In Situ Activation of Helper T Cells in the Lung. Infect. Immun. 69: 4790-4798 [Abstract] [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harbeck, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow